MANAGEMENT OF HORMONE REPLACEMENT THERAPY SIDE-EFFECTS

被引:0
作者
GAMBRELL, RD
机构
来源
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 1994年 / 1卷 / 02期
关键词
HORMONE REPLACEMENT THERAPY; ESTROGEN; PROGESTOGEN;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Side effects of hormone replacement therapy (HRT) may keep a significant number of women from continuation of therapy. These include breast tenderness; edema or bloating; premenstrual syndrome (PMS)-like symptoms such as headache, irritability, depression, and lethargy; and withdrawal bleeding. With the many different progestogens and regimens available, therapy should be individualized to meet the patient's need. Each has its advantages and disadvantages, but it is sometimes possible to eliminate withdrawal bleeding. The continuous combined method of HRT may not be fully endometrium protective because cases of endometrial cancer are beginning to surface. There is increasing evidence that added progestogen may even protect the bones and the breast. When adequate dosages of estrogen are given, there is no adverse effect of HRT on lipids and lipoproteins over the long term. Side effects from added progestogens may be severe in a small percentage of women. However, by adding a mild diuretic, changing the type, dosage, route of administration, or the regimen, usually a progestogen can be found for symptom-free hormone replacement.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 33 条
  • [1] TIMING OF SURGERY DURING MENSTRUAL-CYCLE AND SURVIVAL OF PREMENOPAUSAL WOMEN WITH OPERABLE BREAST-CANCER
    BADWE, RA
    GREGORY, WM
    CHAUDARY, MA
    RICHARDS, MA
    BENTLEY, AE
    RUBENS, RD
    FENTIMAN, IS
    [J]. LANCET, 1991, 337 (8752) : 1261 - 1264
  • [2] BARRAT J, 1990, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V19, P269
  • [3] POSTMENOPAUSAL ESTROGEN USE AND HEART-DISEASE RISK-FACTORS IN THE 1980S - RANCHO-BERNARDO, CALIF, REVISITED
    BARRETTCONNOR, E
    WINGARD, DL
    CRIQUI, MH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (14): : 2095 - 2100
  • [4] THE RISK OF BREAST-CANCER AFTER ESTROGEN AND ESTROGEN PROGESTIN REPLACEMENT
    BERGKVIST, L
    ADAMI, HO
    PERSSON, I
    HOOVER, R
    SCHAIRER, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (05) : 293 - 297
  • [5] BUZDAR AU, 1988, ENDOCRINE MANAGEMENT, P1
  • [6] CHRISTIANSEN C, 1981, LANCET, V1, P459
  • [7] COULAM CB, 1983, JAMA-J AM MED ASSOC, V249, P445
  • [8] BREAST-CANCER INCIDENCE IN WOMEN WITH A HISTORY OF PROGESTERONE DEFICIENCY
    COWAN, LD
    GORDIS, L
    TONASCIA, JA
    JONES, GS
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1981, 114 (02) : 209 - 217
  • [9] CLINICAL AND ENDOMETRIAL EFFECTS OF ESTRADIOL AND PROGESTERONE IN POSTMENOPAUSAL WOMEN
    DARJ, E
    NILSSON, S
    AXELSSON, O
    HELLBERG, D
    [J]. MATURITAS, 1991, 13 (02) : 109 - 115
  • [10] EDEN JA, 1993, SEP N AM MEN SOC SAN